Lucira Health, Inc.

OTCPK:LHDX.Q Stock Report

Market Cap: US$4.2k

Lucira Health Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Lucira Health reports early data for point of care chlamydia and gonorrhea assays

Sep 29

Lucira COVID & Flu test gets emergency use authorization from Health Canada

Aug 11

Lucira Health Sees Strong Revenue Growth But Needs More Cash

Mar 10

Analysts' Revenue Estimates For Lucira Health, Inc. (NASDAQ:LHDX) Are Surging Higher

Nov 25
Analysts' Revenue Estimates For Lucira Health, Inc. (NASDAQ:LHDX) Are Surging Higher

Is Lucira Health (NASDAQ:LHDX) In A Good Position To Invest In Growth?

Jun 29
Is Lucira Health (NASDAQ:LHDX) In A Good Position To Invest In Growth?

Lucira Health appoints medtech veteran Kevin Collins as CRO

May 28

Health Canada issues 'authorization with conditions' for Lucira's COVID-19 test kit

Apr 26

CEO

Lucira Health has no CEO, or we have no data on them.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/10/04 04:12
End of Day Share Price 2023/10/04 00:00
Earnings2022/09/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lucira Health, Inc. is covered by 3 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Derik de BruinBofA Global Research
David ShermanLifeSci Capital, LLC
Brian WeinsteinWilliam Blair & Company L.L.C.